CCT128930 885499-61-6 CCT128930 is a potent, ATP-competitive and selective inhibitor of Akt2 with IC50 of 6 nM, 28-fold greater selectivity for Akt2 than the closely related PKA kinase.

Idasanutlin (RG-7388) 1229705-06-9 Idasanutlin (RG-7388) is a potent and selective p53-MDM2 inhibitor with IC50 of 6 nM.

NMS-P937 1034616-18-6 NMS-P937 (NMS1286937) is an orally available, selective Polo-like Kinase 1 (PLK1) inhibitor with IC50 of 2 nM, 5000-fold selectivity over PLK2/PLK3. Phase 1.

Cobicistat 1004316-88-4 Cobicistat (GS-9350) is a potent and selective inhibitor of CYP3A with IC50 of 30-285 nM.

Daclatasvir 1009119-64-5；1214735-16-6 Daclatasvir (BMS-790052) is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes

Azilsartan Medoxomil 863031-21-4 Azilsartan Medoxomil is a potent angiotensin II type 1 (AT1) receptor antagonist, inhibits the RAAS, with an IC50 of 2.6 nM, exhibits 10,000-fold selectivity over AT2

AS-252424 900515-16-4 AS-252424 is a potent and selective inhibitor of PI3Kγ with IC50 of 33 nM; 10 fold selectivity for PI3Kγ versus PI3Kα.

PHA-767491 845714-00-3 PHA-767491 is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM and 34 nM, respectively.